Hakutulokset

Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time Tekijä Baptist Gallwitz, Allan Vaag, A Falahati, Sten Madsbad

Hae kokoteksti

Drug utilization of oral hypoglycemic agents in a university teaching hospital in India Tekijä S. Go ̈ro ̈g, Prem Kapur, Mohd. Aqil, M. S. Alam, K.K. Pillai

Hae kokoteksti

Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add‐on to metformin monotherapy in Type 2 diabetes mellitus Tekijä Melanie J. Davies, Barrie Chubb, Inger Smith, William J. Valentine

Hae kokoteksti Hae kokoteksti

Pioglitazone Attenuates Atherosclerotic Plaque Inflammation in Patients With Impaired Glucose Tolerance or Diabetes Tekijä Minori Mizoguchi, Nobuhiro Tahara, Atsuko Tahara, Yoshikazu Nitta, Norihiro Kodama, Toyoharu Oba, Kazutoshi Mawatari, Hideo Yasukawa, Hayato Kaida, Masatoshi Ishibashi, Naofumi Hayabuchi, Haruhito Harada, Hisao Ikeda, Sho‐ichi Yamagishi, Tsutomu Imaizumi

Hae kokoteksti

Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients Tekijä Daiji Nagayama, Atsuhito Saiki, Kei Endo, Takashi Yamaguchi, Noriko Ban, Hidetoshi Kawana, Masahiro Ohira, Tomokazu Oyama, Yasushi Miyashita, Keiko Shirai

Hae kokoteksti

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement Tekijä Sanjay Kalra, AH Aamir, Abbas Raza, AK Das, AK Azad Khan, Dina Shrestha, Md Faisal Qureshi, Md Fariduddin, Md Faruque Pathan, Fatema Jawad, Jyoti Bhattarai, Nikhil Tandon, Noel Somasundaram, Prasad Katulanda, Rakesh Sahay, Sanjib Dhungel, Sarita Bajaj, Subhankar Chowdhury, Sujoy Ghosh, S. V. Madhu, Tofail Ahmed, Uditha Bulughapitiya

Hae kokoteksti

Modulation of Adipocytokines Production and Serum NEFA Level by Metformin, Glimepiride, and Sitagliptin in HFD/STZ Diabetic Rats Tekijä Mohamed I. Saad, Maher A. Kamel, Mervat Y. Hanafi

Hae kokoteksti Hae kokoteksti

Pioglitazone Decreases Carotid Intima-Media Thickness Independently of Glycemic Control in Patients With Type 2 Diabetes Mellitus Tekijä Matthias Langenfeld, Thomas Först, C Hohberg, Peter Herbert Kann, G Lübben, Thomas R. Konrad, S. Füllert, C. Sachara, Andreas Pfützner

Hae kokoteksti Hae kokoteksti

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabet... Tekijä B Charbonnel, H. Steinberg, E. Eymard, Lei Xu, Parin Thakkar, Vimalanand S. Prabhu, Melanie J. Davies, Samuel S. Engel

Hae kokoteksti Hae kokoteksti

Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN221... Tekijä Sten Madsbad, Ole Schmitz, Jonas Ranstam, Grethe Jakobsen, David R. Matthews

Hae kokoteksti Hae kokoteksti

Treatment With the Dipeptidyl Peptidase-4 Inhibitor Linagliptin or Placebo Followed by Glimepiride in Patients With Type 2 Diabetes With Moderate to Severe Renal Impairment: A 52-W... Tekijä Markku Laakso, Julio Rosenstock, Per‐Henrik Groop, Anthony Barnett, Baptist Gallwitz, Uwe Hehnke, Ilkka Tamminen, Sanjay Patel, Maximilian von Eynatten, Hans‐Juergen Woerle

Hae kokoteksti Hae kokoteksti

Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides‐induced atrophy in skeletal muscle Tekijä Antonietta Mele, Sara Calzolaro, Gianluigi Cannone, Michela Cetrone, Diana Conte Camerino, Domenico Tricarico

Hae kokoteksti Hae kokoteksti

Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiri... Tekijä A. J. Garber, Robert R. Henry, Robert E. Ratner, Paula M. Hale, Cheng‐Chieh Chang, Bruce W. Bode

Hae kokoteksti

Novel CoQ10 Antidiabetic Mechanisms Underlie Its Positive Effect: Modulation of Insulin and Adiponectine Receptors, Tyrosine Kinase, PI3K, Glucose Transporters, sRAGE and Visfatin... Tekijä Mohamed M. Amin, Gihan F. Asaad, Rania M. Abdelsalam, Hanan S. El‐Abhar, Mahmoud S. Arbid

Hae kokoteksti Hae kokoteksti

Role of Epac2A/Rap1 Signaling in Interplay Between Incretin and Sulfonylurea in Insulin Secretion Tekijä Harumi Takahashi, Tadao Shibasaki, Jae‐Hyung Park, Shihomi Hidaka, Toshimasa Takahashi, Aika Ono, Dae‐Kyu Song, Susumu Seino

Hae kokoteksti

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride a... Tekijä Kjeld Hermansen, Mark Kipnes, Edmund Luo, Debra Fanurik, Hootan Khatami, Peter Stein

Hae kokoteksti Hae kokoteksti

Sulfonylurea Stimulation of Insulin Secretion Tekijä Peter Proks, Frank Reimann, Nicholas Green, Fiona M. Gribble, Frances M. Ashcroft

Hae kokoteksti Hae kokoteksti

Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride Tekijä Werner Kramer, Günter Müller, Frank Girbig, Ulrike Gutjahr, Simone Kowalewski, Detlev Hartz, Hans-Dieter Summ

Hae kokoteksti

HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepir... Tekijä Bo Åhrén, Susan Johnson, Murray Stewart, Deborah T. Cirkel, Fred Yang, Caroline Perry, Mark N. Feinglos

Hae kokoteksti

Glimepiride Promotes Osteogenic Differentiation in Rat Osteoblasts via the PI3K/Akt/eNOS Pathway in a High Glucose Microenvironment Tekijä Pan Ma, Bin Gu, Wei Xiong, Baosheng Tan, Wei Geng, Jun Li, Hongchen Liu

Hae kokoteksti Hae kokoteksti